DE69802512D1 - Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten - Google Patents
Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthaltenInfo
- Publication number
- DE69802512D1 DE69802512D1 DE69802512T DE69802512T DE69802512D1 DE 69802512 D1 DE69802512 D1 DE 69802512D1 DE 69802512 T DE69802512 T DE 69802512T DE 69802512 T DE69802512 T DE 69802512T DE 69802512 D1 DE69802512 D1 DE 69802512D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- solid compositions
- magnesium tartrate
- carnitin
- oral administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000195A IT1291133B1 (it) | 1997-04-07 | 1997-04-07 | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato |
PCT/IT1998/000059 WO1998045250A1 (en) | 1997-04-07 | 1998-03-19 | Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69802512D1 true DE69802512D1 (de) | 2001-12-20 |
DE69802512T2 DE69802512T2 (de) | 2002-08-01 |
Family
ID=11404944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69802512T Expired - Lifetime DE69802512T2 (de) | 1997-04-07 | 1998-03-19 | Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten |
Country Status (17)
Country | Link |
---|---|
US (1) | US6130249A (de) |
EP (1) | EP0971879B1 (de) |
JP (1) | JP2001524078A (de) |
KR (1) | KR100556237B1 (de) |
CN (1) | CN1177808C (de) |
AT (1) | ATE208758T1 (de) |
AU (1) | AU731316B2 (de) |
BR (1) | BR9808489A (de) |
CA (1) | CA2285550C (de) |
DE (1) | DE69802512T2 (de) |
DK (1) | DK0971879T3 (de) |
ES (1) | ES2166596T3 (de) |
HK (1) | HK1025561A1 (de) |
IT (1) | IT1291133B1 (de) |
NZ (1) | NZ500538A (de) |
PT (1) | PT971879E (de) |
WO (1) | WO1998045250A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1305308B1 (it) * | 1999-03-26 | 2001-05-04 | Biosint S P A | Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione |
JP4539096B2 (ja) * | 2004-01-16 | 2010-09-08 | 日油株式会社 | 油性成分被覆l−カルニチン塩粉末およびその用途 |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
CN101209975B (zh) | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
US8996409B2 (en) | 2007-06-06 | 2015-03-31 | Sony Computer Entertainment Inc. | Management of online trading services using mediated communications |
EP2425834A1 (de) * | 2010-09-06 | 2012-03-07 | Lonza Ltd. | Verfahren zur Herstellung von L-Carnitin-Tartrat |
US9105178B2 (en) | 2012-12-03 | 2015-08-11 | Sony Computer Entertainment Inc. | Remote dynamic configuration of telemetry reporting through regular expressions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1153640A (en) * | 1967-04-10 | 1969-05-29 | Soc D Etudes Prod Chimique | A Carnitin Salt |
FR2529545B1 (fr) * | 1982-07-02 | 1985-05-31 | Sanofi Sa | Nouveaux sels de carnitine ainsi que leur procede de preparation |
DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
CA2018137C (en) * | 1989-06-14 | 2000-01-11 | Thomas Scholl | L-carnitine magnesium citrate |
US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
IT1261688B (it) * | 1993-05-28 | 1996-05-29 | Avantgarde Spa | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
-
1997
- 1997-04-07 IT IT97RM000195A patent/IT1291133B1/it active IP Right Grant
-
1998
- 1998-03-19 DE DE69802512T patent/DE69802512T2/de not_active Expired - Lifetime
- 1998-03-19 US US09/381,831 patent/US6130249A/en not_active Expired - Fee Related
- 1998-03-19 ES ES98912694T patent/ES2166596T3/es not_active Expired - Lifetime
- 1998-03-19 DK DK98912694T patent/DK0971879T3/da not_active Application Discontinuation
- 1998-03-19 NZ NZ500538A patent/NZ500538A/xx unknown
- 1998-03-19 AU AU67454/98A patent/AU731316B2/en not_active Ceased
- 1998-03-19 CN CNB988038455A patent/CN1177808C/zh not_active Expired - Fee Related
- 1998-03-19 KR KR1019997008942A patent/KR100556237B1/ko not_active IP Right Cessation
- 1998-03-19 CA CA002285550A patent/CA2285550C/en not_active Expired - Fee Related
- 1998-03-19 AT AT98912694T patent/ATE208758T1/de not_active IP Right Cessation
- 1998-03-19 BR BR9808489-5A patent/BR9808489A/pt not_active Application Discontinuation
- 1998-03-19 JP JP54256598A patent/JP2001524078A/ja not_active Ceased
- 1998-03-19 PT PT98912694T patent/PT971879E/pt unknown
- 1998-03-19 WO PCT/IT1998/000059 patent/WO1998045250A1/en active IP Right Grant
- 1998-03-19 EP EP98912694A patent/EP0971879B1/de not_active Expired - Lifetime
-
2000
- 2000-04-20 HK HK00102415A patent/HK1025561A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2001524078A (ja) | 2001-11-27 |
AU731316B2 (en) | 2001-03-29 |
DE69802512T2 (de) | 2002-08-01 |
IT1291133B1 (it) | 1998-12-29 |
CN1177808C (zh) | 2004-12-01 |
EP0971879A1 (de) | 2000-01-19 |
KR20010005866A (ko) | 2001-01-15 |
ES2166596T3 (es) | 2002-04-16 |
ATE208758T1 (de) | 2001-11-15 |
ITRM970195A1 (it) | 1998-10-07 |
CA2285550C (en) | 2008-07-08 |
CN1251572A (zh) | 2000-04-26 |
EP0971879B1 (de) | 2001-11-14 |
KR100556237B1 (ko) | 2006-03-03 |
DK0971879T3 (da) | 2002-03-25 |
AU6745498A (en) | 1998-10-30 |
PT971879E (pt) | 2002-05-31 |
US6130249A (en) | 2000-10-10 |
NZ500538A (en) | 2001-03-30 |
BR9808489A (pt) | 2000-05-23 |
CA2285550A1 (en) | 1998-10-15 |
WO1998045250A1 (en) | 1998-10-15 |
HK1025561A1 (en) | 2000-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69806590T2 (de) | Feste zusammensetzungen für orale verabreichung die l-carnitine oder alkanoyl-l-carnitin-magnesium-fumarat enthalten | |
DE69810601D1 (de) | Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichung | |
DE69802512D1 (de) | Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten | |
DE69802518T2 (de) | Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten | |
DE69802789D1 (de) | Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin-oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |